Prescription drug · NDA AUTHORIZED GENERIC
Umeclidinium Ellipta (umeclidinium) NDC 66993-189
Umeclidinium bromide 62.5 ug/1 · Aerosol, Powder · Oral · Prasco Laboratories
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 66993-189-97 | 66993018997 | 1 TRAY in 1 CARTON (66993-189-97) / 1 INHALER in 1 TRAY / 30 AEROSOL, POWDER in 1 INHALERMarketed from Apr 6, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Umeclidinium Ellipta
- Generic name (nonproprietary)
- umeclidinium
- Active ingredients
- Umeclidinium bromide — 62.5 ug/1
- Dosage form
- Aerosol, Powder
- Route
- Oral
- Labeler
- Prasco Laboratories
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 205382
- Marketing start
- Listing expires
- Other FDA classes
- Cholinergic Antagonists (Mechanism)
- Identifiers
- Product ID 66993-189_78029af6-3c01-4be0-8439-ec3c22b4abb7SPL ID 78029af6-3c01-4be0-8439-ec3c22b4abb7SPL set ID 763388a5-cc89-4c25-8562-521df679b7e8RxCUI 1539251UNII 7AN603V4JV
- Pharmacologic class
- Anticholinergic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N466993018997followed by a unit qualifier and the quantityPackage 66993-0189-97. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Umeclidinium ELLIPTA is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Umeclidinium ELLIPTA is an anticholinergic indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). ( 1 )
Excerpt only. Read the full label for complete information.